PL2659007T3 - Kompozycje i sposoby do identyfikowania i różnicowania komponent wirusowych multiwalentnych szczepionek przeciwko gorączce załadunkowej - Google Patents

Kompozycje i sposoby do identyfikowania i różnicowania komponent wirusowych multiwalentnych szczepionek przeciwko gorączce załadunkowej

Info

Publication number
PL2659007T3
PL2659007T3 PL11813620T PL11813620T PL2659007T3 PL 2659007 T3 PL2659007 T3 PL 2659007T3 PL 11813620 T PL11813620 T PL 11813620T PL 11813620 T PL11813620 T PL 11813620T PL 2659007 T3 PL2659007 T3 PL 2659007T3
Authority
PL
Poland
Prior art keywords
identifying
methods
viral components
shipping fever
fever vaccines
Prior art date
Application number
PL11813620T
Other languages
English (en)
Polish (pl)
Inventor
Dale Wade Weise
James Robert Harris
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of PL2659007T3 publication Critical patent/PL2659007T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PL11813620T 2010-12-27 2011-12-21 Kompozycje i sposoby do identyfikowania i różnicowania komponent wirusowych multiwalentnych szczepionek przeciwko gorączce załadunkowej PL2659007T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201061427404P 2010-12-27 2010-12-27
EP11813620.9A EP2659007B1 (en) 2010-12-27 2011-12-21 Methods for identifying and differentiating viral components of multivalent shipping fever vaccines

Publications (1)

Publication Number Publication Date
PL2659007T3 true PL2659007T3 (pl) 2017-08-31

Family

ID=45532015

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11813620T PL2659007T3 (pl) 2010-12-27 2011-12-21 Kompozycje i sposoby do identyfikowania i różnicowania komponent wirusowych multiwalentnych szczepionek przeciwko gorączce załadunkowej

Country Status (15)

Country Link
US (1) US9238843B2 (enExample)
EP (1) EP2659007B1 (enExample)
JP (1) JP6027023B2 (enExample)
CN (1) CN103403191B (enExample)
AR (1) AR084358A1 (enExample)
AU (1) AU2011352801B2 (enExample)
BR (1) BR112013016467A2 (enExample)
CA (1) CA2822798C (enExample)
ES (1) ES2613537T3 (enExample)
MX (1) MX348307B (enExample)
NZ (1) NZ611657A (enExample)
PL (1) PL2659007T3 (enExample)
PT (1) PT2659007T (enExample)
TW (1) TWI513821B (enExample)
WO (1) WO2012092054A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109563555A (zh) * 2016-05-06 2019-04-02 起源生物织物有限公司 培养的皮革及由其制作的产品
CN106906307A (zh) * 2017-03-10 2017-06-30 中国农业科学院特产研究所 牛副流感病毒3型病毒nano‑PCR检测试剂盒及其制备方法
CN113913461A (zh) * 2021-11-15 2022-01-11 贵州大学 牛病毒性腹泻e0-e2基因重组腺病毒疫苗构建方法
KR102827389B1 (ko) * 2021-12-03 2025-07-03 대한민국 소바이러스성설사 바이러스 유전아형 동시감별 진단 키트 및 진단방법
US12553093B1 (en) * 2025-03-26 2026-02-17 Wolf of Zion, Inc. Methods of detecting, identifying and quantifying wild spike protein and covid vaccine spike proteins

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3939350A (en) 1974-04-29 1976-02-17 Board Of Trustees Of The Leland Stanford Junior University Fluorescent immunoassay employing total reflection for activation
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4277437A (en) 1978-04-05 1981-07-07 Syva Company Kit for carrying out chemically induced fluorescence immunoassay
US4458066A (en) 1980-02-29 1984-07-03 University Patents, Inc. Process for preparing polynucleotides
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US4973679A (en) 1981-03-27 1990-11-27 University Patents, Inc. Process for oligonucleo tide synthesis using phosphormidite intermediates
US4415732A (en) 1981-03-27 1983-11-15 University Patents, Inc. Phosphoramidite compounds and processes
DE3329892A1 (de) 1983-08-18 1985-03-07 Köster, Hubert, Prof. Dr., 2000 Hamburg Verfahren zur herstellung von oligonucleotiden
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4800159A (en) 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
FR2596761B1 (fr) 1986-04-08 1988-05-20 Commissariat Energie Atomique Derives de nucleosides et leur utilisation pour la synthese d'oligonucleotides
US4992051A (en) * 1987-11-03 1991-02-12 Novagene, Inc. Infectious bovine rhinotracheitis virus mutants, methods for the production of same and methods for the use of same
US5491225A (en) 1991-12-19 1996-02-13 Hoffmann-La Roche Inc. PCR primers for detection of legionella species and methods for controlling visual intensity in hybridization assays
US5279721A (en) 1993-04-22 1994-01-18 Peter Schmid Apparatus and method for an automated electrophoresis system
DE69518316T2 (de) 1994-05-10 2001-03-29 American Home Products Corp., Madison Modifizierter,verbesserter,lebender brsv impfstoff
FR2751229B1 (fr) * 1996-07-19 1998-11-27 Rhone Merieux Formule de vaccin polynucleotidique notamment contre la pathologie respiratoire des bovins
EP1104676A1 (en) * 1999-11-30 2001-06-06 Boehringer Ingelheim Vetmedica Gmbh Safe attenuated bovine viral diarrhea viruses for use in pregnant cows
US20060084052A1 (en) * 2001-03-27 2006-04-20 Smithkline Beecham Corp. Detection of viable agents
EP1297110B1 (en) * 2000-06-23 2009-07-22 Intervet International BV Attenuated bovine respiratory syncytial virus
US20030124512A1 (en) * 2000-10-18 2003-07-03 Lieven Stuyver Simultaneous quantification of nucleic acids in diseased cells
EP1594537B1 (en) * 2003-02-19 2012-10-24 Merial Vaccination or immunization using a prime-boost regimen against brsv, bhv-1, bvdv, bpi-3
BRPI0508941A (pt) 2004-03-17 2007-08-14 Pharmacia & Upjohn Co Llc método de vacinação contra infecção de bvdv testicular
US20090068223A1 (en) 2005-11-15 2009-03-12 Boehringer Ingelheim Vetmedica, Inc. Combination vaccine comprising an attenuated bovine viral diarrhea virus
EP2026839A4 (en) 2005-12-14 2009-04-01 Univ Oklahoma RNA VIRUS VACCINE AND METHODS
US8354514B2 (en) * 2007-01-12 2013-01-15 Lawrence Livermore National Security, Llc Multiplex detection of agricultural pathogens
CN101696453B (zh) * 2009-11-02 2012-01-25 东北农业大学 检测牛病毒性腹泻病毒逆转录环介导等温扩增反应试剂盒的制备方法
BR112013016503A2 (pt) * 2010-12-27 2018-05-22 Lilly Co Eli composições e método de vacina de vírus da diarreia viral bovina tipo 1b.

Also Published As

Publication number Publication date
NZ611657A (en) 2015-04-24
TW201307571A (zh) 2013-02-16
JP6027023B2 (ja) 2016-11-16
CA2822798C (en) 2016-11-01
MX2013007586A (es) 2013-10-17
CN103403191B (zh) 2016-05-18
EP2659007B1 (en) 2016-11-16
AU2011352801B2 (en) 2015-05-21
CA2822798A1 (en) 2012-07-05
US20130266934A1 (en) 2013-10-10
AU2011352801A1 (en) 2013-06-27
TWI513821B (zh) 2015-12-21
AR084358A1 (es) 2013-05-08
US9238843B2 (en) 2016-01-19
JP2014502846A (ja) 2014-02-06
WO2012092054A3 (en) 2012-12-27
MX348307B (es) 2017-06-06
CN103403191A (zh) 2013-11-20
PT2659007T (pt) 2017-01-18
EP2659007A2 (en) 2013-11-06
ES2613537T3 (es) 2017-05-24
BR112013016467A2 (pt) 2018-09-18
WO2012092054A2 (en) 2012-07-05

Similar Documents

Publication Publication Date Title
ZA201404797B (en) Influenza virus vaccines and uses thereof
SG11201400743VA (en) Influenza virus vaccines and uses thereof
ZA201405864B (en) Cd47 antibodies and methods of use thereof
BR112014029872A2 (pt) método de preparação de uma bebida e dispositivo de preparação por infusão
PT3725807T (pt) Anticorpos anti-cd47 e métodos de utilização destes
ZA201403760B (en) Anti-cd98 antibodies and methods of use thereof
ZA201307968B (en) Adeno-asociated virus virions with variant capsid and methods of use thereof
IL232055B (en) Anti-1htra antibodies and methods of use
IL228018A0 (en) New modulators and methods of use
IL229419B (en) Heat-stable vaccines and methods for their preparation
SG10201705523UA (en) Thermal cycler apparatus and related methods
ZA201404675B (en) Anti-lrp5 antibodies and methods of use
SG11201502757QA (en) Anti-c16orf54 antibodies and methods of use thereof
CO6870003A2 (es) Vacunas bovinas y métodos
PL2575873T3 (pl) Zatężanie i liofilizacja antygenów szczepionkowych grypy
EP2670843A1 (en) Multivalent vaccines for rabies virus and filoviruses
IL222723A0 (en) Respiratory syncytial virus antigenic compositions and methods
DK2707480T3 (da) Viruslignende partikler og fremgangsmåde til fremstilling heraf
PT2659007T (pt) Composições e métodos de identificação e diferenciação de componentes virais de vacinas multivalentes contra a febre dos transportes
IL227324A0 (en) Method for manufacturing composition comprising local anesthetic, heparinoid, and buffer
IL229403A0 (en) Means and methods for extending the hardening time of magnesium phosphate cements
EP2632487A4 (en) VIRUS VACCINE AND MANUFACTURING METHOD THEREFOR
GB201107933D0 (en) Glue dot and method of manufacture thereof
PL396260A1 (pl) Sposób otrzymywania hydrochinonu i pirokatechiny
PL395201A1 (pl) Sposób analizy termicznej i aparat do analizy termicznej